← Back to Search

Video Intervention for Advance Care Planning

N/A
Waitlist Available
Led By Michael Paasche-Orlow, MD, MPH
Research Sponsored by Boston Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
NH adult > 55 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 weeks, 3 months, 6 months
Awards & highlights

Study Summary

This trial is testing a video intervention to help Native Hawaiians make decisions about their healthcare, including palliative and hospice care services. The goal is to improve communication and empower patients to tell their story and share their preferences with family and clinicians.

Who is the study for?
This trial is for Native Hawaiian adults over the age of 55 who have seen their primary care provider at least twice before. They must be referred by a community organization and able to participate in discussions about future medical care planning. Those with severe visual impairments or significant cognitive issues cannot join.Check my eligibility
What is being tested?
The study tests an Advance Care Planning video program called I kua na'u, designed for Native Hawaiians. It aims to inform them about medical options like palliative care and encourage sharing their health care wishes through personal video stories with family and doctors.See study design
What are the potential side effects?
Since this intervention involves educational videos, there are no direct physical side effects expected from participating in this trial. However, discussing end-of-life preferences can be emotionally impactful.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 55 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 weeks, 3 months, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 weeks, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in ACP Knowledge (Pre-Post Trial)
Change in ACP Knowledge (RCT)
Secondary outcome measures
ACP Documentation (Pre-Post Trial)
ACP Documentation (RCT)
Change in Advance Care Planning Engagement (Pre-Post Trial)
+9 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Randomized Clinical Trial: Intervention GroupExperimental Treatment1 Intervention
In the ambulatory clinics we will conduct a randomized controlled trial (N=110), and randomize (1:1) to either the video (intervention) or usual care (control) arm. The intervention group will use the ACP video decision aid. All participants will have a baseline survey, be randomized to intervention or control, and receive a post-intervention survey, which includes the same items as the baseline survey. Follow-up in person or by phone interviews will be done at three and six months.
Group II: Pre-Post TrialExperimental Treatment1 Intervention
Native Hawaiian participants from Homestead and Group Assisted Living (N=110) will partake in a pre-post study design. Participants will receive a baseline survey (as described below), view the ACP video intervention, and receive a post-intervention survey, which includes the same items as the baseline survey. In-person or phone interviews will be done at three and six months.
Group III: Randomized Clinical Trial: Control GroupActive Control1 Intervention
In the ambulatory clinics we will conduct a randomized controlled trial (N=110), and randomize (1:1) to either the video (intervention) or usual care (control) arm. The control group will receive usual care. All participants will have a baseline survey, be randomized to intervention or control, and receive a post-intervention survey, which includes the same items as the baseline survey. Follow-up in person or by phone interviews will be done at three and six months.

Find a Location

Who is running the clinical trial?

Boston Medical CenterLead Sponsor
382 Previous Clinical Trials
869,179 Total Patients Enrolled
2 Trials studying Advance Care Planning
10,839 Patients Enrolled for Advance Care Planning
Tufts Medical CenterLead Sponsor
253 Previous Clinical Trials
253,178 Total Patients Enrolled
1 Trials studying Advance Care Planning
10,802 Patients Enrolled for Advance Care Planning
National Institute of Nursing Research (NINR)NIH
579 Previous Clinical Trials
10,376,162 Total Patients Enrolled
4 Trials studying Advance Care Planning
291 Patients Enrolled for Advance Care Planning

Media Library

I kua na'u "Let Me Carry Out Your Last Wishes" Clinical Trial Eligibility Overview. Trial Name: NCT04771208 — N/A
Advance Care Planning Research Study Groups: Randomized Clinical Trial: Intervention Group, Pre-Post Trial, Randomized Clinical Trial: Control Group
Advance Care Planning Clinical Trial 2023: I kua na'u "Let Me Carry Out Your Last Wishes" Highlights & Side Effects. Trial Name: NCT04771208 — N/A
I kua na'u "Let Me Carry Out Your Last Wishes" 2023 Treatment Timeline for Medical Study. Trial Name: NCT04771208 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any additional opportunities for patient participation in this research project?

"Data found on clinicaltrials.gov suggests that, as of the 18th October 2022, this trial is not enrolling patients. However, there are 17 other active studies seeking participants at present. The original post date for this study was November 1st, 2022."

Answered by AI

What objectives is this experiment attempting to meet?

"This clinical trial intends to measure the impact of the intervention on participants' knowledge about ACP. Additionally, two questions related to end-of-life health care preferences will be asked before and after the implementation of this procedure. The study also aims to assess Advance Care Planning Engagement (ACPE) employing a Likert Scale from 0-5, where higher scores represent increased engagement."

Answered by AI
~90 spots leftby Feb 2025